
FDA approves Sanofi anticancer treatment delivered through Enable Injections on-body device
Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on-body device.

Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on-body device.

Thread-based electronics that conform to the body could point toward softer, less obtrusive health monitors

Zeta Surgical announced today that it received FDA 510(k) clearance for its TMS Robotic System as a stereotaxic instrument.

Spiro Robotics earned FDA 510(k) clearance for its handheld, dual image-guided system for tracheal intubation, Spiro-VISTA.

The new aerated material could enable longer-lasting bandages, implants, and wearable sensors.

Neuspera Medical announced today that the Centers for Medicare & Medicaid Services (CMS) confirmed its SNM system’s billing code.

Jenscare Scientific announced today that it received CE mark approval for its LuX-Valve plus under EU Medical Device Regulation (MDR).

Johnson & Johnson (NYSE:JNJ) announced today that it received FDA approval for its dual-energy ThermoCool SmartTouch SF platform (DE STSF).

Vera Therapeutics’ atacicept, to be marketed as Trutakna, will go up against Novartis, Otsuka and possibly Vertex in the kidney disease primary IgA nephropathy after receiving an accelerated FDA approval.

Beckman Coulter’s assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline.